Shandong Xinhua Pharmaceutical Company Limited reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 1,831.25 million compared to CNY 1,768.12 million a year ago. Revenue was CNY 1,831.25 million compared to CNY 1,768.12 million a year ago.

Net income was CNY 108.5 million compared to CNY 100.28 million a year ago. Basic earnings per share was CNY 0.17 compared to CNY 0.16 a year ago. Diluted earnings per share was CNY 0.17 compared to CNY 0.16 a year ago.